A Reversal for Concordia International Corp Is Not Near. The Stock Declines Again

 A Reversal for Concordia International Corp Is Not Near. The Stock Declines Again

The stock of Concordia International Corp (TSE:CXR) is a huge mover today! About 109,985 shares traded hands. Concordia International Corp (TSE:CXR) has declined 86.18% since April 18, 2016 and is downtrending. It has underperformed by 90.74% the S&P500.
The move comes after 8 months negative chart setup for the $213.09M company. It was reported on Nov, 22 by Barchart.com. We have $3.95 PT which if reached, will make TSE:CXR worth $14.92 million less.

Concordia International Corp (TSE:CXR) Ratings Coverage

Out of 4 analysts covering Concordia Healthcare Corp (TSE:CXR), 0 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 0 are positive. $135 is the highest target while $2 is the lowest. The $28.40 average target is 568.24% above today’s ($4.25) stock price. Concordia Healthcare Corp has been the topic of 26 analyst reports since August 11, 2015 according to StockzIntelligence Inc. RBC Capital Markets maintained Concordia International Corp (TSE:CXR) on Monday, October 24 with “Outperform” rating. Goldman Sachs maintained it with “” rating and $34 target price in Friday, July 22 report. The rating was maintained by RBC Capital Markets on Monday, October 17 with “Outperform”. RBC Capital Markets maintained the shares of CXR in a report on Tuesday, October 11 with “Outperform” rating. The stock has “Hold” rating given by Mackie on Thursday, December 3. RBC Capital Markets maintained it with “Outperform” rating and $73 target price in Monday, June 20 report. On Tuesday, August 11 the stock rating was maintained by RBC Capital Markets with “Outperform”. The stock of Concordia International Corp (TSE:CXR) has “Outperform” rating given on Monday, October 31 by RBC Capital Markets. RBC Capital Markets maintained Concordia International Corp (TSE:CXR) on Tuesday, June 7 with “Outperform” rating. On Friday, January 8 the stock rating was maintained by RBC Capital Markets with “Outperform”.

More recent Concordia International Corp (TSE:CXR) news were published by: Finance.Yahoo.com which released: “Concordia International Corp. Announces Communication With CMA” on October 25, 2016. Also Prnewswire.com published the news titled: “Concordia International Corp. Announces CEO Transition Plan” on October 21, 2016. Prnewswire.com‘s news article titled: “Shareholder Class Action Filed Against Concordia International Corp. – CXRX” with publication date: August 17, 2016 was also an interesting one.

Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $213.09 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment